Fig. 7From: Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysisForrest plots of the pooled durable remission rate in the LD-IVIg group (A) and the HD-IVIg group (B)Back to article page